The Washington PostDemocracy Dies in Darkness

Pharmaceutical industry likely to shatter its lobbying record as it works to shape Democrats’ spending bill

A years-long battle over prescription drug prices reaches its apex as the industry spends tens of millions to alter the plan.

November 5, 2021 at 7:00 a.m. EDT
Rep. Andy Kim (D-N.J.) has made lowering seniors’ health-care costs and expanding their access to Medicare a signature issue. (Mandel Ngan/AFP/Getty Images)
12 min

In September, Rep. Andy Kim (D-N.J.) began noticing mailers arriving at homes across his district, including his own and that of his parents, with an alarming message. The mailers alleged that Kim was intent on preventing Medicare patients from getting the drugs they needed.

That was news to Kim, who has made lowering seniors’ health-care costs and expanding their access to Medicare a signature issue. The mailer, along with a slew of digital ads and text messages, was sponsored by a group called A Healthy Future, LLC, and claimed that Kim and other New Jersey Democrats wanted to cut off “access to lifesaving medicines” and shift Medicare money into other social safety-net programs.